Wealth Enhancement Trust Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.6K Hold
55
– – ﹤0.01% 587
2026
Q2
$10.5K Hold
55
– – ﹤0.01% 720
2026
Q1
$9.29K Hold
55
– – ﹤0.01% 596
2025
Q4
$9.28K Buy
+55
New +$8.93K ﹤0.01% 573

Other funds holding IBB

Wealth Enhancement Trust Services's IBB Position: Q3 2026 in Review

Wealth Enhancement Trust Services held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 55 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #587.

Wealth Enhancement Trust Services first reported a position in IBB in Q4 2025 and has held it in 4 quarters since. 1,019 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Wealth Enhancement Trust Services held 55 shares of iShares Biotechnology ETF worth $11.6K as of Q3 2026.
  • Wealth Enhancement Trust Services left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q3 2026, its #587 holding.
  • Wealth Enhancement Trust Services first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 4 quarters since.
  • 1,019 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.